GS
75
2
BK
74
2
WU
32
2
UPS
60
9
LH
43
-2
HRB
57
5
ACN
52
3
MCHP
41
4
GIS
31
3
DD
63
3
HBI
59
4
WFC
79
4
NRG
49
-3
VTR
47
-7
XYL
49
4
RSG
71
3
LB
63
22
AN
58
4
NAVI
52
5
F
58
11
GS
75
2
BK
74
2
WU
32
2
UPS
60
9
LH
43
-2
HRB
57
5
ACN
52
3
MCHP
41
4
GIS
31
3
DD
63
3
HBI
59
4
WFC
79
4
NRG
49
-3
VTR
47
-7
XYL
49
4
RSG
71
3
LB
63
22
AN
58
4
NAVI
52
5
F
58
11
Financhill
Back

Evaxion Biotech AS Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
5

EVAX
Evaxion Biotech AS

Last Price:
1.42
Seasonality Move:
-40.11%
Sell
22

ADAP
Adaptimmune Therapeutics PLC

Last Price:
0.66
Seasonality Move:
53.66%
Sell
5
Evaxion Biotech AS (EVAX) is a Sell

Is Evaxion Biotech AS a Buy, Sell or Hold?

  • The current Evaxion Biotech AS [EVAX] share price is $1.49. The Score for EVAX is 5, which is 90% below its historic median score of 50, and infers higher risk than normal.
  • EVAX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
22
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.66. The Score for ADAP is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EVAX Stock Price Chart

What is Evaxion Biotech AS's stock price today?

  • The Evaxion Biotech AS share price today is $1.49
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVAX is experiencing buying pressure, which is a positive indicator for future bullish movement.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $0.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.

EVAX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 28.35 Sell
Chaikin Money Flow: 12953 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.76 - 2.8) Sell
Bollinger Bands (100): (2.35 - 3.25) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 39.76 Sell
Chaikin Money Flow: 1207506 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.66 - 0.82) Sell
Bollinger Bands (100): (0.8 - 1.2) Sell

EVAX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.54 Sell
20-day SMA: 2.19 Sell
50-day SMA: 2.59 Sell
200-day SMA: 3.18 Sell
8-day EMA: 1.63 Sell
20-day EMA: 2.02 Sell
50-day EMA: 2.44 Sell
200-day EMA: 3.89 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.65 Buy
20-day SMA: 0.73 Sell
50-day SMA: 0.84 Sell
200-day SMA: 1.11 Sell
8-day EMA: 0.67 Sell
20-day EMA: 0.72 Sell
50-day EMA: 0.83 Sell
200-day EMA: 0.99 Sell

Evaxion Biotech AS Earnings Growth & EVAX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.57 per share, and an increase next year of $0.05 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.

Evaxion Biotech AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):